GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its ...

JMP Securities analyst David Turkaly reiterated a Hold rating on Globus Medical (GMED – Research Report) today. The company’s shares opened ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...

Globus Medical (GMED) announced the completion of its previously disclosed acquisition of Nevro (NVRO). The acquisition of Nevro further ...

Globus Medical, Inc. GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers comprehensive, life-changing solutions for the ...

Check Out Our Latest Research Report on GMED Globus Medical Stock Performance Shares of GMED opened at $72.07 on Friday. The firm has a fifty day moving average of $80.64 and a 200-day moving ...

Globus Medical GMED has outperformed the market over the past 10 years by 1.08% on an annualized basis producing an average annual return of 11.62%. Currently, Globus Medical has a market ...